A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatment of Vulvovaginal Atrophy
- Conditions
- Menopause
- Interventions
- Drug: DR-2041bOther: PlaceboDrug: DR-2041a
- First Posted Date
- 2006-08-08
- Last Posted Date
- 2015-04-20
- Lead Sponsor
- Duramed Research
- Target Recruit Count
- 622
- Registration Number
- NCT00361569
- Locations
- 🇺🇸
Duramed Investigational Site, Tacoma, Washington, United States
A Clinical Trial to Demonstrate the Efficacy and Safety of Cenestin 0.3 mg for the Treatment of Hot Flashes
- First Posted Date
- 2006-01-09
- Last Posted Date
- 2012-07-03
- Lead Sponsor
- Duramed Research
- Target Recruit Count
- 400
- Registration Number
- NCT00272935
- Locations
- 🇺🇸
Duramed Investigational Site, Tacoma, Washington, United States
A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive.
- Conditions
- Contraception
- Interventions
- Drug: Levonorgestrel/EE 0.15/0.03 mg and EE 0.01 mg tablets
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2014-04-08
- Lead Sponsor
- Duramed Research
- Target Recruit Count
- 320
- Registration Number
- NCT00196352
- Locations
- 🇺🇸
Duramed Investigational Site, Norfolk, Virginia, United States
A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea
- Conditions
- Amenorrhea
- Interventions
- Drug: DR-2021bDrug: DR-2021cDrug: DR-2021dDrug: DR-2021eOther: PlaceboDrug: DR-2021a
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2014-07-30
- Lead Sponsor
- Duramed Research
- Target Recruit Count
- 180
- Registration Number
- NCT00196391
- Locations
- 🇺🇸
Duramed Investigational Ste, Dawsonville, Georgia, United States
🇺🇸Duramed Investigational Site, Newport News, Virginia, United States
A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the Treatment of Vulvovaginal Atrophy
- Conditions
- Menopause
- Interventions
- Other: Placebo
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2013-09-02
- Lead Sponsor
- Duramed Research
- Target Recruit Count
- 300
- Registration Number
- NCT00196378
- Locations
- 🇺🇸
Duramed Investigational Site, Tacoma, Washington, United States
Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contraceptive
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2016-11-16
- Lead Sponsor
- Duramed Research
- Target Recruit Count
- 2235
- Registration Number
- NCT00196326
- Locations
- 🇺🇸
Duramed Investigational Site, Tacoma, Washington, United States
A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain
- Conditions
- Dysmenorrhea
- Interventions
- Drug: levonorgestrel/EE 0.15/0.03 and EE 0.01 mg tabletsDrug: Placebo tablet
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2016-09-22
- Lead Sponsor
- Duramed Research
- Target Recruit Count
- 95
- Registration Number
- NCT00196313
- Locations
- 🇺🇸
Duramed Investigational Site, Salt Lake City, Utah, United States
A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain
- Conditions
- Dysmenorrhea
- Interventions
- Drug: levonorgestrel/EE 0.15/0.03 and EE 0.01 mg tabletsDrug: levonorgestrel/EE 0.15/0.03 mg tablets and placebo
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2014-05-12
- Lead Sponsor
- Duramed Research
- Target Recruit Count
- 97
- Registration Number
- NCT00196365
- Locations
- 🇺🇸
Duramed Investigational Site, Tacoma, Washington, United States
Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder
- Conditions
- Urinary Incontinence
- Interventions
- Other: PlaceboDrug: DR-3001aDrug: DR-3001b
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2012-08-20
- Lead Sponsor
- Duramed Research
- Target Recruit Count
- 800
- Registration Number
- NCT00196404
- Locations
- 🇨🇦
Duramed Investigational Site, Toronto, Ontario, Canada
🇺🇸Duramed Research Site, Tacoma, Washington, United States
🇺🇸Duremed Research Site, San Diego, California, United States
A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2016-07-22
- Lead Sponsor
- Duramed Research
- Target Recruit Count
- 315
- Registration Number
- NCT00196339
- Locations
- 🇨🇦
Duramed Investigational Site, Pointe-Claire, Quebec, Canada
🇺🇸Duramed Investiational Site, Ocala, Florida, United States
🇺🇸Duramed Investigational site, Garden City, New York, United States